|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pei D: Matrix metalloproteinases target
protease-activated receptors on the tumor cell surface. Cancer
Cell. 7:207–208. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pittayapruek P, Meephansan J, Prapapan O,
Komine M and Ohtsuki M: Role of Matrix Metalloproteinases in
Photoaging and Photocarcinogenesis. Int J Mol Sci. 17:8682016.
View Article : Google Scholar
|
|
4
|
Poola I, DeWitty RL, Marshalleck JJ,
Bhatnagar R, Abraham J and Leffall LD: Identification of MMP-1 as a
putative breast cancer predictive marker by global gene expression
analysis. Nat Med. 11:481–483. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yang R, Xu Y, Li P, Zhang X, Wang J, Gu D
and Wang Y: Combined upregulation of matrix metalloproteinase-1 and
proteinase-activated receptor-1 predicts unfavorable prognosis in
human nasopharyngeal carcinoma. Onco Targets Ther. 6:1139–1146.
2013.PubMed/NCBI
|
|
6
|
Guan X, Wang X, Luo H and Wu J, Zhang X
and Wu J: Matrix metalloproteinase 1, 3 and 9 polymorphisms and
esophageal squamous cell carcinoma risk. Med Sci Monit.
20:2269–2274. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Botta GP, Reginato MJ, Reichert M, Rustgi
AK and Lelkes PI: Constitutive K-RasG12D activation of ERK2
specifically regulates 3D invasion of human pancreatic cancer cells
via MMP-1. Mol Cancer Res. 10:183–196. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cai QW, Li J, Li XQ, Wang JQ and Huang Y:
Expression of STAT3, MMP-1 and TIMP-1 in gastric cancer and
correlation with pathological features. Mol Med Rep. 5:1438–1442.
2012.PubMed/NCBI
|
|
9
|
Liu H, Kato Y, Erzinger SA, Kiriakova GM,
Qian Y, Palmieri D, Steeg PS and Price JE: The role of MMP-1 in
breast cancer growth and metastasis to the brain in a xenograft
model. BMC Cancer. 12:5832012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hua H, Li M, Luo T, Yin Y and Jiang Y:
Matrix metalloproteinases in tumorigenesis: An evolving paradigm.
Cell Mol Life Sci. 68:3853–3868. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Iida J and McCarthy JB: Expression of
collagenase-1 (MMP-1) promotes melanoma growth through the
generation of active transforming growth factor-beta. Melanoma Res.
17:205–213. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ma D, Hovey RL, Zhang Z, Fye S, Huettner
PC, Borecki IB and Rader JS: Genetic variations in EGFR and ERBB4
increase susceptibility to cervical cancer. Gynecol Oncol.
131:445–450. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Schrevel M, Gorter A, Kolkman-Uljee SM,
Trimbos JB, Fleuren GJ and Jordanova ES: Molecular mechanisms of
epidermal growth factor receptor overexpression in patients with
cervical cancer. Mod Pathol. 24:720–728. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wagner EF and Nebreda AR: Signal
integration by JNK and p38 MAPK pathways in cancer development. Nat
Rev Cancer. 9:537–549. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sadowski L, Pilecka I and Miaczynska M:
Signaling from endosomes: Location makes a difference. Exp Cell
Res. 315:1601–1609. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Guéguinou M, Gambade A, Félix R, Chantôme
A, Fourbon Y, Bougnoux P, Weber G, Potier-Cartereau M and Vandier
C: Lipid rafts, KCa/ClCa/Ca2+ channel complexes and EGFR signaling:
Novel targets to reduce tumor development by lipids? Biochim
Biophys Acta. 1848:2603–2620. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Staubach S and Hanisch FG: Lipid rafts:
Signaling and sorting platforms of cells and their roles in cancer.
Expert Rev Proteomics. 8:263–277. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mollinedo F and Gajate C: Lipid rafts as
major platforms for signaling regulation in cancer. Adv Biol Regul.
57:130–146. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen X and Resh MD: Cholesterol depletion
from the plasma membrane triggers ligand-independent activation of
the epidermal growth factor receptor. J Biol Chem. 277:49631–49637.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Roepstorff K, Thomsen P, Sandvig K and van
Deurs B: Sequestration of epidermal growth factor receptors in
non-caveolar lipid rafts inhibits ligand binding. J Biol Chem.
277:18954–18960. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Irwin ME, Bohin N and Boerner JL: Src
family kinases mediate epidermal growth factor receptor signaling
from lipid rafts in breast cancer cells. Cancer Biol Ther.
12:718–726. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang Z, Song T, Jin Y, Pan J, Zhang L,
Wang L and Li P: Epidermal growth factor receptor regulates MT1-MMP
and MMP-2 synthesis in SiHa cells via both PI3-K/AKT and MAPK/ERK
pathways. Int J Gynecol Cancer. 19:998–1003. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Pugniere P, Banzet S, Chaillou T, Mouret C
and Peinnequin A: Pitfalls of reverse transcription quantitative
polymerase chain reaction standardization: Volume-related
inhibitors of reverse transcription. Anal Biochem. 415:151–157.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Macdonald JL and Pike LJ: A simplified
method for the preparation of detergent-free lipid rafts. J Lipid
Res. 46:1061–1067. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang D and Brodt P: Type 1 insulin-like
growth factor regulates MT1-MMP synthesis and tumor invasion via PI
3-kinase/Akt signaling. Oncogene. 22:974–982. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Egeblad M and Werb Z: New functions for
the matrix metalloproteinases in cancer progression. Nat Rev
Cancer. 2:161–174. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Janes PW, Ley SC and Magee AI: Aggregation
of lipid rafts accompanies signaling via the T cell antigen
receptor. J Cell Biol. 147:447–461. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhou X, Xu CJ, Wang JX, Dai T, Ye YP, Cui
YM, Liao WT, Wu XL and Ou JP: Metastasis-Associated in Colon
Cancer-1 Associates With Poor Prognosis and Promotes Cell Invasion
and Angiogenesis in Human Cervical Cancer. Int J Gynecol Cancer.
25:1353–1363. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lee JY, Lee C, Hahn S, Kim MA, Kim HS,
Chung HH, Kim JW, Park NH and Song YS: Prognosis of adenosquamous
carcinoma compared with adenocarcinoma in uterine cervical cancer:
A systematic review and meta-analysis of observational studies. Int
J Gynecol Cancer. 24:289–294. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Song C, Zhu S, Wu C and Kang J: Histone
deacetylase (HDAC) 10 suppresses cervical cancer metastasis through
inhibition of matrix metalloproteinase (MMP) 2 and 9 expression. J
Biol Chem. 288:28021–28033. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bonnans C, Chou J and Werb Z: Remodelling
the extracellular matrix in development and disease. Nat Rev Mol
Cell Biol. 15:786–801. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lai HC, Chu CM, Lin YW, Chang CC, Nieh S,
Yu MH and Chu TY: Matrix metalloproteinase 1 gene polymorphism as a
prognostic predictor of invasive cervical cancer. Gynecol Oncol.
96:314–319. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
McCawley LJ and Matrisian LM: Matrix
metalloproteinases: They're not just for matrix anymore! Curr Opin
Cell Biol. 13:534–540. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Tan S, de Vries EG, van der Zee AG and de
Jong S: Anticancer drugs aimed at E6 and E7 activity in
HPV-positive cervical cancer. Curr Cancer Drug Targets. 12:170–184.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Saha SK and Khuda-Bukhsh AR: Berberine
alters epigenetic modifications, disrupts microtubule network, and
modulates HPV-18 E6-E7 oncoproteins by targeting p53 in cervical
cancer cell HeLa: A mechanistic study including molecular docking.
Eur J Pharmacol. 744:132–146. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Soonthornthum T, Arias-Pulido H, Joste N,
Lomo L, Muller C, Rutledge T and Verschraegen C: Epidermal growth
factor receptor as a biomarker for cervical cancer. Ann Oncol.
22:2166–2178. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Mathur RS and Mathur SP: Vascular
endothelial growth factor (VEGF) up-regulates epidermal growth
factor receptor (EGF-R) in cervical cancer in vitro: This action is
mediated through HPV-E6 in HPV-positive cancers. Gynecol Oncol.
97:206–213. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Suprynowicz FA, Disbrow GL, Krawczyk E,
Simic V, Lantzky K and Schlegel R: HPV-16 E5 oncoprotein
upregulates lipid raft components caveolin-1 and ganglioside GM1 at
the plasma membrane of cervical cells. Oncogene. 27:1071–1078.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Irwin ME, Mueller KL, Bohin N, Ge Y and
Boerner JL: Lipid raft localization of EGFR alters the response of
cancer cells to the EGFR tyrosine kinase inhibitor gefitinib. J
Cell Physiol. 226:2316–2328. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Roy M, Kung HJ and Ghosh PM: Statins and
prostate cancer: Role of cholesterol inhibition vs. prevention of
small GTP-binding proteins. Am J Cancer Res. 1:542–561.
2011.PubMed/NCBI
|
|
41
|
Herrero-Martin G and López-Rivas A:
Statins activate a mitochondria-operated pathway of apoptosis in
breast tumor cells by a mechanism regulated by ErbB2 and dependent
on the prenylation of proteins. FEBS Lett. 582:2589–2594. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Kwan ML, Habel LA, Flick ED, Quesenberry
CP and Caan B: Post-diagnosis statin use and breast cancer
recurrence in a prospective cohort study of early stage breast
cancer survivors. Breast Cancer Res Treat. 109:573–579. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Cardwell CR, Hicks BM, Hughes C and Murray
LJ: Statin use after diagnosis of breast cancer and survival: A
population-based cohort study. Epidemiology. 26:68–78. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zhang Y, Wang L, Zhang M, Jin M, Bai C and
Wang X: Potential mechanism of interleukin-8 production from lung
cancer cells: An involvement of EGF-EGFR-PI3K-Akt-Erk pathway. J
Cell Physiol. 227:35–43. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Vallianou NG, Kostantinou A, Kougias M and
Kazazis C: Statins and cancer. Anticancer Agents Med Chem.
14:706–712. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Hsieh SC, Tsai JP, Yang SF, Tang MJ and
Hsieh YH: Metformin inhibits the invasion of human hepatocellular
carcinoma cells and enhances the chemosensitivity to sorafenib
through a downregulation of the ERK/JNK-mediated NF-κB-dependent
pathway that reduces uPA and MMP-9 expression. Amino Acids.
46:2809–2822. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Wang F, Ke ZF, Wang R, Wang YF, Huang LL
and Wang LT: Astrocyte elevated gene-1 (AEG-1) promotes
osteosarcoma cell invasion through the JNK/c-Jun/MMP-2 pathway.
Biochem Biophys Res Commun. 452:933–939. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Liu B, Li G, Wang X and Liu Y: A furin
inhibitor downregulates osteosarcoma cell migration by
downregulating the expression levels of MT1-MMP via the Wnt
signaling pathway. Oncol Lett. 7:1033–1038. 2014.PubMed/NCBI
|
